Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

raloxifene hydrochloride-loaded Eudragit® S100/sorbitan monostearate/caprylic/capric triglyceride mixture nanocapsule suspension

Based on

1 Articles
2014 Most recent source

Composition

1

sorbitan monostearate/caprylic/capric triglyceride mixture

Type Complex Compound
Formula
Role core
2

poly(methacrylic acid-co-methyl methacrylate)

EudragitS-100
Type Polymer
Formula
Role layer
3

raloxifene hydrochloride

raloxifene evista
Type Single Compound
Formula C28H28ClNO4S
Role loaded material

Properties

General physical and chemical properties

Property Value Source
delta back scattering

2 more entries available to subscribers only.

Or, view sample content

Applications

Area Application Source
medicine/veterinary

0 more entry available to subscribers only.

Or, view sample content

Characterization

Method Source
dynamic light scattering

2 more entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Source
human breast cancer cell line MCF-7

0 more entry available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • raloxifene hydrochloride
  • sorbitan monostearate
  • poly(methacrylic acid-co-methyl methacrylate)
See all (4)
  1. xb5AHWRXgZp0RvVG9ZnGEZk9Cr0j
Product

raloxifene hydrochloride-loaded Eudragit® S100/sorbitan monostearate/caprylic/capric triglyceride mixture nanocapsule suspension

Method 2

Type: Physical formation
Source:
Product

raloxifene hydrochloride-loaded Eudragit® S100/sorbitan monostearate/caprylic/capric triglyceride mixture nanocapsule suspension

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial